Pharmaceuticals / Medical Devices
As a national strategic emerging industry, biopharmaceuticals covers segments such as chemical pharmaceuticals, biological products, in vitro diagnostics, and medical devices. It is characterized by strict regulation, high compliance requirements, and zero tolerance for errors, with extremely stringent requirements for whole-process production control, data retention, and batch traceability. Driven by the digital economy, China's biopharmaceutical industry is flourishing. In particular, as oversight by domestic and international drug regulators such as the FDA continues to tighten, GMP standards, electronic batch records, full-process traceability, and compliance audits have become hard market-entry requirements, compelling enterprises to achieve compliant production, controllable batches, and fully traceable production operations through digitalization.

Management Challenges
Compared with other industries, the biopharmaceutical industry strictly follows GMP compliance and batch traceability management requirements, with an extremely low quality error tolerance. The traditional production management model has many compliance shortcomings and cannot meet drug regulatory inspection standards, constraining enterprises' compliance clearance and production efficiency. The industry faces the following management challenges:
- Stringent compliance control with demanding GMP requirements across the whole process; heavy workloads for change, deviation, and traceability management
- A wide variety of materials with shelf-life sensitivity, complex batch management, and great difficulty in mix-up prevention and first-in-first-out control
- Highly sensitive process parameters; variations in manual operation can easily trigger batch quality fluctuation
- Production is mostly small-batch and high-mix, with frequent line changeovers, insufficient scheduling flexibility, and low equipment utilization
- Lagging real-time collection of equipment operating data, with stringent requirements for the real-time performance of equipment alerts and status monitoring
- Fragmented cross-departmental information; production, quality, and laboratory data are not interconnected, anomaly response lags, and it is difficult to build closed-loop compliance control
Solution
The Morewis digital solution for biopharmaceuticals focuses on core scenarios such as GMP implementation, electronic batch records, full-process compliant traceability and closed-loop quality control. Addressing the industry's compliance pain points, it builds a digital factory system that stands up to regulatory inspections and helps enterprises produce compliantly while improving quality and efficiency. Strictly aligned with GMP and UDI compliance requirements, the solution solidifies production processes, operating standards and compliance rules into standardized system workflows, forming a digital management system that integrates production execution, batch record management, quality traceability, equipment control and document compliance — managing and monitoring production in real time, error-proofing and tracking materials and processes end to end, and automatically collecting, monitoring and alerting on production equipment.
On top of this, AI is embedded in the business loop as an intelligent engine: a knowledge base consolidates GMP regulations, SOPs and compliance rules for natural-language lookup, reducing compliance deviations; AI quality inspection identifies product and material abnormalities, replacing manual visual inspection; SPC control charts intelligently interpret fluctuations, locate anomalies and provide suggestions; predictive maintenance warns of equipment failures in advance; and a smart data Q&A platform queries production, quality and equipment data conversationally for rapid anomaly location. Together these form a closed loop of perception — analysis — action, moving compliance control from recording after the fact to real-time insight and early intervention, improving GMP compliance and product quality stability.
Building a Biopharmaceutical Digital Factory from the Manufacturing Process
Addressing Core Needs
- Build an error-proofing and full-process traceability system that meets GMP and UDI compliance; an AI knowledge base turns regulations and SOPs into conversational, on-demand lookups that reduce risk.
- Automatically collect process data and archive it into electronic batch records (E-DHR) to support precise traceability audits; AI verifies record completeness and parameter consistency, shortening audit cycles.
- Integrate planning, material kitting and manufacturing to reduce waiting waste from plan changes; smart data Q&A gives real-time visibility of kitting and progress for rapid impact assessment.
- Make production transparent and fine-grained, standardizing process operations to avoid human deviation; AI quality inspection identifies product and material abnormalities, replacing visual inspection with consistent judgment.
- Collect process quality data level by level via barcodes for forward and backward 4M1E traceability; SPC intelligently interprets parameter fluctuations for early warnings.
- Build a closed quality loop across IQC, PQC, FQC and QA with control, alerts and abnormality handling; AI alerts come with cause interpretation and improvement suggestions, upgraded to recommended actions.
- TPM equipment management connects key equipment for monitoring, alerts and OEE visualization; predictive maintenance uses vibration, sound and operating data to forecast equipment health, turning after-the-fact response into proactive intervention.
- Break down data silos and enable data-driven refined management for better compliance collaboration; management, quality and planning roles query cross-department data through smart data Q&A, improving decision response.
- Systematically control warehouse materials with built-in incoming inspection, standardized batch, expiry and FIFO management, and full-chain GMP traceability; AI vision assists in identifying material abnormalities, preventing mix-ups and errors.
- Adapt to medical compliance regulations with standardized approval and e-signature systems to meet document compliance requirements; policy, equipment and quality knowledge bases support conversational lookup, so execution is always evidence-based.
Example — Overview of End-to-End Value Stream Control in Biopharmaceuticals
Application Benefits
- Establish a standardized production error-proofing and full-process control mechanism, consolidate the GMP compliance system, and reduce audit risks
- Fully automatic collection of data across the whole production process and digitized batch records, achieving compliant traceability
- Break down data barriers between production, quality, materials, and equipment, making the entire production process visible, controllable, and traceable
- Closed-loop quality control across the whole process, stabilizing product quality consistency
- Digital equipment control to ensure compliant, stable, and efficient operation of production equipment
- Data-driven management, providing precise data support for compliance upgrading, quality improvement, and capacity optimization